Dr. Salman Bhai is an Assistant Professor in the Department of Neurology at the University of Texas Southwestern Medical Center and Director of the Neuromuscular Center at the Institute of Exercise and Environmental Medicine (IEEM) at Texas Health Presbyterian Hospital Dallas. He earned his B.S. in mathematics at Duke University and his M.D. from Harvard Medical School, where he earned multiple research grants including the Bertarelli Fellowship and a Wilderness Medicine Society grant. He completed his internship, neurology residency, and neuromuscular fellowship at Harvard: internship at Brigham and Women’s Hospital and residency and fellowship in a joint program between Massachusetts General Hospital and Brigham and Women’s Hospital.
Dr. Bhai specializes in the evaluation, diagnosis, and treatment of neuromuscular disorders. He specifically focuses on patients with inflammatory and metabolic myopathies as well as those with immune checkpoint inhibitor complications.
His research focuses on understanding how muscles communicate with other organ systems, particularly when muscle is inflamed, like in myositis. The goal of his research is to better understand, diagnose, and treat patients with myositis. This will be achieved through exercise and muscle physiology studies of myositis patients by analyzing biospecimens for molecular perturbations. He also works to offer clinical trials for myositis patients.
Clinical Trials: site PI on two metabolic myopathy trials sponsored by Reneo Pharmaceuticals
Research PI: muscle signaling in inflammatory conditions, physiological and immune perturbations in inflammatory myopathies
Research collaborations: immune molecular phenotyping in checkpoint inhibitor complications (David Gerber – UTSW lab), biomarkers of muscle damage (Ning Liu, Lin Xu – UTSW)
Dr. Bhai is dedicated to neurologic medical education. During his neurology residency, he worked to create a multi-modal curriculum for internal medicine residents and lead the implementation of the program. He also dedicated his time to teach parts of the curriculum. He continues to work with medical students, neurology residents, and neuromuscular fellows to further neurology education.
Dr. Bhai is dedicated to helping patients and their families understand and navigate difficult conditions by providing exceptional clinical care.
- Medical School
- Harvard Medical School (2015)
- Brigham and Women's Hospital (2016), Internal Medicine
- Massachusetts General Hospital & Brigham and Women's Hospital (2019), Neurology
- Massachusetts General Hospital & Brigham and Women's Hospital (2020), Neuromuscular Disease
- Checkpoint inhibitor complications
- Exercise physiology
- Inflammatory myopathies
- Metabolic myopathies
- Prospective Double-Blinded Randomized Field-Based Clinical Trial of Metoclopramide and Ibuprofen for the Treatment of High Altitude Headache and Acute Mountain Sickness.
- Irons HR, Salas RN, Bhai SF, Gregorie WD, Harris NS, Wilderness Environ Med 2020 Mar 31 1 38-43
- Mystery Case: A 64-year-old woman with subacute encephalopathy.
- Bhai S, Biffi A, Bakhadirov K, Prasad S, Neurology 2015 Aug 85 8 e64-5
- Neurosyphilis Update: Atypical is the New Typical.
- Bhai S, Lyons JL, Curr Infect Dis Rep 2015 May 17 5 481
- Alternating ictal and postictal nystagmus.
- Bhai S, Malik AN, Bakhadirov K, Prasad S, Neurol Clin Pract 2014 Dec 4 6 522-523
- Complete anterograde amnesia from simultaneous bilateral hippocampal infarction.
- Bhai S, Biffi A, Bakhadirov K, Prasad S, Neurohospitalist 2014 Jul 4 3 165-6
- Shunt survival after failed endoscopic treatment of hydrocephalus.
- Warf BC, Bhai S, Kulkarni AV, Mugamba J, J Neurosurg Pediatr 2012 Dec 10 6 463-70
- Programming and reprogramming neuronal subtypes in the central nervous system.
- Rouaux C, Bhai S, Arlotta P, Dev Neurobiol 2012 Jul 72 7 1085-98
- Costs and benefits of neurosurgical intervention for infant hydrocephalus in sub-Saharan Africa.
- Warf BC, Alkire BC, Bhai S, Hughes C, Schiff SJ, Vincent JR, Meara JG, J Neurosurg Pediatr 2011 Nov 8 5 509-21
- The death domain-containing kinase RIP1 regulates p27(Kip1) levels through the PI3K-Akt-forkhead pathway.
- Park S, Ramnarain DB, Hatanpaa KJ, Mickey BE, Saha D, Paulmurugan R, Madden CJ, Wright PS, Bhai S, Ali MA, Puttaparthi K, Hu W, Elliott JL, Stuve O, Habib AA EMBO Rep. 2008 Aug 9 8 766-73